Related Experiment Videos

Prediction of therapeutic response in acute myelocytic leukemia

H D Preisler, Y M Rustum

Haematology and Blood Transfusion

|January 1, 1979

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models.

British journal of cancer·2014

Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1alpha expression, resulting in reduced angiogenesis.

Oncogene·2006

S-phase modulation by irinotecan: pilot studies in advanced solid tumors.

Cancer chemotherapy and pharmacology·2005

Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study.

Annals of oncology : official journal of the European Society for Medical Oncology·2003

The effects of the farnesyl transferase inhibitor FTI L-778,123 on normal, myelodysplastic, and myeloid leukemia bone marrow progenitor proliferation in vitro.

Leukemia & lymphoma·2003

Chemotherapeutic strategies for treatment of colorectal cancer: present and future developments.

Clinical colorectal cancer·2002

See all related articles